日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours

肿瘤突变负荷对实体瘤生存结局影响的系统评价和荟萃分析

Meng, Aijia; Yuile, Alexander; Sim, Hao-Wen; Thavaneswaran, Subotheni; Noor, Humaira; Yeung, Jacky; Mehta, Ashish; Powell, Joseph; Zaman, Ashraf

Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank

不断演变的分类系统对弥漫性胶质瘤样本库的影响:来自悉尼脑肿瘤库的经验

Satgunaseelan, Laveniya; Xian, Elissa; Madani, Daniel; Gamage, Kasuni K; Hallal, Susannah M; Gorolay, Vineet; Sim, Hao-Wen; Mason, Sofia; Buckland, Michael E; Shivalingam, Brindha; Alexander, Kimberley L

Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology

澳大利亚异柠檬酸脱氢酶突变型胶质瘤成人患者的管理:神经肿瘤合作试验组的专家立场声明

Pinkham, Mark B; Sim, Hao-Wen; Jeffree, Rosalind L; Lasocki, Arian; Legge, Dianne M; Saran, Frank; Satgunaseelan, Laveniya; Gan, Hui K

Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.

针对突变型 p53 依赖性胰腺癌中的 NPY/NPY1R 信号轴进行治疗可抑制转移

Chambers Cecilia R, Watakul Supitchaya, Schofield Peter, Howell Anna E, Zhu Jessie, Tran Alice M H, Kuepper Nadia, Reed Daniel A, Murphy Kendelle J, Channon Lily M, Pereira Brooke A, Tyma Victoria M, Lee Victoria, Trpceski Michael, Henry Jake, Melenec Pauline, Abdulkhalek Lea, Nobis Max, Metcalf Xanthe L, Ritchie Shona, Cadell Antonia, Stoehr Janett, Magenau Astrid, Chacon-Fajardo Diego, Chitty Jessica L, O'Connell Savannah, Zaratzian Anaiis, Tayao Michael, Da Silva Andrew, Lyons Ruth J, Goldstein Leonard D, Dale Ashleigh, Rookyard Alexander, Connolly Angela, Crossett Ben, Tran Yen T H, Kaltzis Peter, Vennin Claire, Dinevska Marija, Croucher David R, Samra Jaswinder, Mittal Anubhav, Weatheritt Robert J, Philp Andrew, Del Monte-Nieto Gonzalo, Zhang Lei, Enriquez Ronaldo F, Cox Thomas R, Shi Yan-Chuan C, Pinese Mark, Waddell Nicola, Sim Hao-Wen, Chtanova Tatyana, Wang Yingxiao, Joshua Anthony M, Chantrill Lorraine, Evans Thomas R Jeffry, Gill Anthony J, Morton Jennifer P, Pajic Marina, Christ Daniel, Herzog Herbert, Timpson Paul, Herrmann David

A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling

针对经全面基因组分析鉴定出的具有 NTRK 融合或 NTRK mRNA 过度表达的肿瘤,开展拉罗替尼的 II 期试验

Thavaneswaran, Subotheni; Sim, Hao-Wen; Grady, John; Espinoza, David; Huang, Min Li; Lin, Frank; McGrath, Margaret; Desai, Jayesh; Charakidis, Michail; Brown, Michael; Kansara, Maya; Simes, John; Thomas, David

Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey

CDKN2A/B纯合缺失IDH突变型星形细胞瘤的临床结局和治疗管理——一项队列研究和治疗模式调查

Yuile, Alexander; Satgunaseelan, Laveniya; Alexander, Kimberley L; Thavaneswaran, Subotheni; Sim, Hao-Wen; Krasovitsky, Michael; Kong, Benjamin Y; Miller, Samuel; Buckland, Michael E; Lee, Maggie; Wei, Grace; Kastelan, Marina; Wong, Mark; Wilson, Isabella; Bayly, Angela; Varikatt, Winny; Lwin, Zarnie; Turner, Cassie; Back, Michael F; Pavlakis, Nick; Wei, Joe Q; Hudson, Amanda; Chan, David L; Wheeler, Helen R; Lee, Adrian

TIP-19. INTERROGATE-GBM Phase I trial: Immunotherapy peptide vaccine targeting cytomegalovirus (CMV) antigens in glioblastoma

TIP-19. INTERROGATE-GBM I期试验:针对胶质母细胞瘤中巨细胞病毒(CMV)抗原的免疫疗法肽疫苗

Nannenga, Brent L; Gonen, Tamir; Chung, Sylvia; Holst, Jeff; Teng, Christina; Cooper, Adam; Wei, Joe; Koh, Eng-Siew; Yeo, Nicholas; Sim, Hao-Wen; Killen, Andrew J; Gayaman, Regienald; Lynch, Sarah; Mandala, Anusha; Murray, Clare; Joshi, Swapna; McDonald, Kerrie; Ashley, David; Desjardins, Annick; Sampson, John; Archer, Gerald; Lemech, Charlotte; Hovey, Elizabeth

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma

低级别和间变性胶质瘤分子靶向治疗伞式研究 (LUMOS-2):一项针对复发性 IDH 突变型 2/3 级胶质瘤的 II 期前瞻性、多中心、开放标签、多组、生物标志物导向、信号探索性伞式临床试验的研究方案

McParland, Kristen; Koh, Eng-Siew; Kong, Benjamin; Sim, Hao-Wen; Thavaneswaran, Subotheni; Yip, Sonia; Barnes, Elizabeth H; Ballinger, Mandy L; Thomas, David M; De Abreu Lourenco, Richard; Simes, John; Sebastian, Lucille; Wheeler, Patrick J; Spyridopoulos, Desma; Hawkins, Cynthia; Pitz, Marshall; O'Callaghan, Christopher; Gan, Hui K

Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience

立体定向放射治疗寡转移性前列腺癌的真实世界临床结果:澳大利亚的经验

Shekar, Samantha; Crumbaker, Megan; Joshua, Anthony; Yam, Andrew; Stricker, Phillip; Yuen, Carlo; Ende, David; Namdarian, Benjamin; Thompson, James; Kooner, Raji; O'Neill, Gordon; Mo, Jeremy; Sim, Hao-Wen; Hruby, George; Kasraei, Farshad; Ho, Annie; De Leon, Jeremy

Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma

化疗剂量强度和年龄与尤文氏肉瘤患者预后的关系

Klingberg, Danielle; Bae, Susie; Zhou, Deborah Di-Xin; Sim, Hao-Wen; Cai, Ruilin; Anazodo, Antoinette; Grimison, Peter; Lewis, Craig; Lee, Yeh Chen